605 related articles for article (PubMed ID: 36094829)
1. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
Mellon L; Doyle F; Hickey A; Ward KD; de Freitas DG; McCormick PA; O'Connell O; Conlon P
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012854. PubMed ID: 36094829
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing thrombosis in solid organ transplant recipients.
Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
[TBL] [Abstract][Full Text] [Related]
4. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
[TBL] [Abstract][Full Text] [Related]
5. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
[TBL] [Abstract][Full Text] [Related]
6. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.
Cross AJ; Elliott RA; Petrie K; Kuruvilla L; George J
Cochrane Database Syst Rev; 2020 May; 5(5):CD012419. PubMed ID: 32383493
[TBL] [Abstract][Full Text] [Related]
7. Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.
Chan S; Ng S; Chan HP; Pascoe EM; Playford EG; Wong G; Chapman JR; Lim WH; Francis RS; Isbel NM; Campbell SB; Hawley CM; Johnson DW
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013209. PubMed ID: 32799356
[TBL] [Abstract][Full Text] [Related]
8. Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC; Chung EY; McGregor DO; Bachmann F; Strippoli GF
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD005015. PubMed ID: 31637698
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
10. Interventions for improving sleep quality in people with chronic kidney disease.
Natale P; Ruospo M; Saglimbene VM; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2019 May; 5(5):CD012625. PubMed ID: 31129916
[TBL] [Abstract][Full Text] [Related]
11. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
Karpe KM; Talaulikar GS; Walters GD
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006750. PubMed ID: 28730648
[TBL] [Abstract][Full Text] [Related]
13. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological interventions for heart failure in people with chronic kidney disease.
Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
[TBL] [Abstract][Full Text] [Related]
15. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
[TBL] [Abstract][Full Text] [Related]
16. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
17. eHealth interventions for people with chronic kidney disease.
Stevenson JK; Campbell ZC; Webster AC; Chow CK; Tong A; Craig JC; Campbell KL; Lee VW
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012379. PubMed ID: 31425608
[TBL] [Abstract][Full Text] [Related]
18. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
19. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
20. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]